InfuSystems Holdings, Inc.

INFU Healthcare Medical Devices

InfuSystems Holdings, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $143.4 million, up 6.36% from fiscal 2024. In the quarter to June 2026, revenue grew 2.59%, EPS grew 33.3%, free cash flow fell 66.5% and total debt fell 22.5%, each against the same quarter a year earlier. Revenue growth for five consecutive years; insiders bought in the last twelve months.

13.33 0.59 −4.24%
Market cap
$277.2M
P/E
31.7×
Fwd P/E
21.7×
Dividend yield
—
F-score
8/9
Altman Z
3.74
Beneish M
−3.30
Dividend safety
n/a

InfuSystems Holdings, Inc. (INFU) P/E ratio

Alert me on P/E ratio

As of 16 October 2026, InfuSystems Holdings, Inc. (INFU) trades at a P/E ratio of 31.7×. Over the past ten years it has ranged from 0.0× (March 2023) to 5,800× (June 2023); the current reading is higher than 59% of that period. That is above the Medical Devices industry median of 23.2× and above the Healthcare sector median of 23.0×.

P/E ratio, daily

Embed this chart

Annual newest first

Period P/E ratio Change
FY2025 28.0× (66.83%)
FY2024 84.5× (68.41%)
FY2023 267× —
FY2022 0.0× —
FY2021 243× 1,027.04%
FY2020 21.6× (82.29%)
FY2019 122× —
FY2018 0.0× —
FY2017 0.0× —
FY2016 0.0× —

Quarterly newest first

Period P/E ratio Change
Jun 2026 23.0× (5.41%)
Mar 2026 24.3× (13.35%)
Dec 2025 28.0× (29.65%)
Sep 2025 39.8× 46.87%
42 more quarters

Against its own ten years

Low 0.0× High 5,800×
Ten-year median 26.8×
Current reading's percentile 37

P/E ratio against peers

What P/E ratio is

Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.

Stock Price ÷ EPS (Basic) (TTM)

The full definition of P/E ratio →

More on INFU